NDC Package 50242-133-01 Trastuzumab

Solution - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

50242-133-01

Package Description:

120 L in 1 TANK

Product Code:

50242-133

Non-Proprietary Name:

Trastuzumab

Substance Name:

Trastuzumab

Usage Information:

Trastuzumab is used to treat certain breast or stomach cancers that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.

11-Digit NDC Billing Format:

50242013301

Product Type:

Drug For Further Processing

Labeler Name:

Genentech, Inc.

Dosage Form:

Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.

Active Ingredient(s):

TRASTUZUMAB 25 g/L

Sample Package:

N/A

Marketing Category:

DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.

Start Marketing Date:

09-25-1998

Listing Expiration Date:

12-31-2024

Exclude Flag:

Unfinished Product:

Yes

Code Structure:

50242 - Genentech, Inc.
- 50242-133 -
  - 50242-133-01 - 120 L in 1 TANK

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
50242-133-02	300 L in 1 TANK

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 50242-133-01?

The NDC Packaged Code 50242-133-01 is assigned to an UNFINISHED drug package of 120 l in 1 tank of Trastuzumab, drug for further processing labeled by Genentech, Inc.. The product's dosage form is solution and is administered via form.

Is NDC 50242-133 included in the NDC Directory?

Yes, Trastuzumab is an UNFINISHED PRODUCT with code 50242-133 that is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on September 25, 1998 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 50242-133-01?

The 11-digit format is 50242013301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	50242-133-01	5-4-2	50242-0133-01

Table of Contents